Oxford Nanopore Technologies Stock Surges on Strong Preliminary H1 Revenues

Original from: genomeweb

Shares of Oxford Nanopore Technologies jumped 16 percent on Monday after the company reported strong preliminary revenues for the first half of 2025.

For the six months ended June 30, the UK nanopore sequencing firm estimated revenues to be approximately £105 million ($141.4 million), up 25 percent from £84.1 million in the first half of 2024. Revenues came in ahead of the company's expectations and represent 28 percent growth on a constant currency basis.

The company saw strong growth in both research and applied markets, which grew approximately 22 percent and 33 percent, respectively. Applied markets included biopharma, clinical, and industrial segments.

By geography, growth was led by Europe, the Middle East, Africa, and India (EMEAI) as well as by Asia Pacific, both of which delivered more than 30 percent year-over-year revenue growth on a constant currency basis.

Despite the ongoing funding uncertainty in the US research environment, revenues in the Americas grew by 17 percent on a constant currency basis, driven by increasing demand in applied markets.

Looking at products, growth was strongest across the PromethIon platform, with revenues up by approximately 59 percent year over year.

Oxford Nanopore said it continues to make progress on its path to profitability, delivering a year-over-year and sequential reduction in adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) loss, supported by the company's "disciplined cost management and gross profit growth" in the period.

As of June 30, the firm had approximately £337 million in cash, cash equivalents, and other liquid investments.

For full-year 2025, Oxford Nanopore maintained its guidance of 20 percent to 23 percent growth on a constant currency basis. The company said it is "on track" to execute its 2025 goals across all metrics, citing "continued momentum across the business." 

The firm plans to report its full financial H1 results on Sept. 2.

In afternoon trading on the London Stock Exchange, Oxford Nanopore's shares were up 16 percent at £1.71 ($2.30).

Source: Oxford Nanopore Technologies Stock Surges on Strong Preliminary H1 Revenues